References
- Rodriguez RJ. Management of respiratory distress syndrome: an update. Respir Care 2003;48:279-86.
- Henderson-Smart DJ, Wilkinson A, Raynes-Greenow CH. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database Syst Rev 2002;(4):CD002770.
- Hayes D Jr, Feola DJ, Murphy BS, Shook LA, Ballard HO. Pathogenesis of bronchopulmonary dysplasia. Respiration 2010;79:425-36. https://doi.org/10.1159/000242497
- Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011;23:305-13. https://doi.org/10.1097/MOP.0b013e328346577f
- Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update. Neonatology 2017;111:107-25. https://doi.org/10.1159/000448985
- Blennow M, Bohlin K. Surfactant and noninvasive ventilation. Neonatology 2015;107:330-6. https://doi.org/10.1159/000381122
- Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26-30.
- Cummings JJ, Polin RA; Committee on Fetus and Newborn, American Academy of Pediatrics. Noninvasive respiratory support. Pediatrics 2016;137(1). https://doi.org/10.1542/peds.2015-3758.
- Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994;331:1051-5. https://doi.org/10.1056/NEJM199410203311603
- Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007;(4):CD003063.
- Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007;27:422-7. https://doi.org/10.1038/sj.jp.7211754
- Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics 2004;113:e560-3. https://doi.org/10.1542/peds.113.6.e560
- Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol 2005;25:703-8. https://doi.org/10.1038/sj.jp.7211381
- Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010;125:e1402-9. https://doi.org/10.1542/peds.2009-2131
- Nakhshab M, Tajbakhsh M, Khani S, Farhadi R. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study. Pediatr Neonatol 2015;56:88-94. https://doi.org/10.1016/j.pedneo.2014.05.006
- Isayama T, Chai-Adisaksopha C, McDonald SD. Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: a systematic review and meta-analysis. JAMA Pediatr 2015;169:731-9. https://doi.org/10.1001/jamapediatrics.2015.0510
- Brix N, Sellmer A, Jensen MS, Pedersen LV, Henriksen TB. Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study. BMC Pediatr 2014;14:155. https://doi.org/10.1186/1471-2431-14-155
- Cherif A, Hachani C, Khrouf N. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants. Am J Perinatol 2008;25:647-52. https://doi.org/10.1055/s-0028-1090590
- Dani C, Corsini I, Poggi C. Risk factors for intubation-surfactantextubation (INSURE) failure and multiple INSURE strategy in preterm infants. Early Hum Dev 2012;88 Suppl 1:S3-4.
- Najafian B, Saburi A, Fakhraei SH, Afjeh A, Eghbal F, Noroozian R. Predicting factors of INSURE failure in low birth-weight neonates with respiratory distress syndrome: a logistic regression model. Iran J Neonatol 2014;5:30-4.
- Doyle DJ. Arterial/alveolar oxygen tension ratio: a critical appraisal. Can Anaesth Soc J 1986;33:471-4. https://doi.org/10.1007/BF03010973
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9. https://doi.org/10.1164/ajrccm.163.7.2011060
- Finer NN, Carlo WA, Duara S, Fanaroff AA, Donovan EF, Wright LL, et al. Delivery room continuous positive airway pressure/positive endexpiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics 2004;114:651-7. https://doi.org/10.1542/peds.2004-0394
- Alallah J. Early CPAP versus surfactant in extremely preterm infants. J Clin Neonatol 2012;1:12-3. https://doi.org/10.4103/2249-4847.92233
- SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362:1970-9. https://doi.org/10.1056/NEJMoa0911783
- Seong IC, Shin YS, Chang YP. Prophylactic administration of surfactant with nasal continuous positive airway pressure in preterm infants with gestational age less than 30 weeks. J Korean Soc Neonatol 2012;19:253-61. https://doi.org/10.5385/jksn.2012.19.4.253
- Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009;123:137-42. https://doi.org/10.1542/peds.2007-3501
- Dani C, Corsini I, Bertini G, Fontanelli G, Pratesi S, Rubaltelli FF. The INSURE method in preterm infants of less than 30 weeks' gestation. J Matern Fetal Neonatal Med 2010;23:1024-9. https://doi.org/10.3109/14767050903572174
- Gopel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011;378:1627-34. https://doi.org/10.1016/S0140-6736(11)60986-0
- Gopel W, Kribs A, Hartel C, Avenarius S, Teig N, Groneck P, et al. Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paediatr 2015;104:241-6. https://doi.org/10.1111/apa.12883
- Dargaville PA, Ali SKM, Jackson HD, Williams C, De Paoli AG. Impact of minimally invasive surfactant therapy in preterm infants at 29-32 weeks gestation. Neonatology 2018;113:7-14. https://doi.org/10.1159/000480066
- Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 2013;131:e502-9. https://doi.org/10.1542/peds.2012-0603
- More K, Sakhuja P, Shah PS. Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr 2014;168:901-8. https://doi.org/10.1001/jamapediatrics.2014.1148
Cited by
- History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea vol.34, pp.25, 2018, https://doi.org/10.3346/jkms.2019.34.e175